Published in Curr Opin Neurol on October 01, 2016
Lipid glycosylation: a primer for histochemists and cell biologists. Histochem Cell Biol (2016) 0.75
Quantitative proteomics reveals Piccolo as a candidate serological correlate of recovery from Guillain-Barré syndrome. Oncotarget (2016) 0.75
Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain (2008) 2.60
Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice. Brain (2010) 1.90
The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis. Nat Med (2010) 1.63
Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides. Infect Immun (2006) 1.34
Tetanus toxin is internalized by a sequential clathrin-dependent mechanism initiated within lipid microdomains and independent of epsin1. J Cell Biol (2006) 1.23
Ganglioside antibodies and neuropathies. Curr Opin Neurol (2008) 1.15
Sialoadhesin promotes rapid proinflammatory and type I IFN responses to a sialylated pathogen, Campylobacter jejuni. J Immunol (2012) 1.14
Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome. Infect Immun (2002) 1.13
Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain (2004) 1.10
Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest Ophthalmol Vis Sci (2009) 1.09
Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve (2004) 1.09
Analysis of lectin binding to glycolipid complexes using combinatorial glycoarrays. Glycobiology (2009) 1.06
Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function. J Neurosci (2002) 1.05
Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol (2003) 1.04
Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy. J Neurosci (2005) 1.02
Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction. J Physiol (2009) 1.01
Combinatorial glycoarray. Methods Mol Biol (2012) 1.01
The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice. J Clin Invest (2009) 1.00
Characterisation of the immunoglobulin variable region gene usage encoding the murine anti-ganglioside antibody repertoire. J Neuroimmunol (2005) 0.98
Recent developments in Miller Fisher syndrome and related disorders. Curr Opin Neurol (2005) 0.98
Innate murine B cells produce anti-disialosyl antibodies reactive with Campylobacter jejuni LPS and gangliosides that are polyreactive and encoded by a restricted set of unmutated V genes. J Neuroimmunol (2004) 0.94
Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding. Brain (2003) 0.94
Acute immunoinflammatory neuropathy: update on Guillain-Barré syndrome. Curr Opin Neurol (2002) 0.92
An open label clinical trial of complement inhibition in multifocal motor neuropathy. J Peripher Nerv Syst (2011) 0.92
Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome. Ann Neurol (2005) 0.92
Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury. Brain (2003) 0.92
Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis. J Neuroimmunol (2011) 0.91
Adenovirus type 21-associated acute flaccid paralysis during an outbreak of hand-foot-and-mouth disease in Sarawak, Malaysia. Clin Infect Dis (2003) 0.90
Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome. J Neuroimmunol (2008) 0.89
Identity, developmental restriction and reactivity of extralaminar cells capping mammalian neuromuscular junctions. J Cell Sci (2008) 0.89
Complex gangliosides as autoantibody targets at the neuromuscular junction in Miller Fisher syndrome: a current perspective. Neurochem Res (2002) 0.88
Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy. J Clin Invest (2012) 0.87
Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies. PLoS One (2012) 0.87
Solid phase immunoadsorption for therapeutic and analytical studies on neuropathy-associated anti-GM1 antibodies. Glycobiology (2006) 0.86
Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice. PLoS One (2012) 0.85
C5 inhibitor rEV576 protects against neural injury in an in vitro mouse model of Miller Fisher syndrome. J Peripher Nerv Syst (2008) 0.85
The pre-synaptic motor nerve terminal as a site for antibody-mediated neurotoxicity in autoimmune neuropathies and synaptopathies. J Anat (2013) 0.84
Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions. Glia (2005) 0.84
Antibodies to MOG in NMO: a seasoned veteran finds a new role. Neurology (2012) 0.83
Neuromuscular synaptic transmission in aged ganglioside-deficient mice. Neurobiol Aging (2009) 0.83
Neuronal expression of GalNAc transferase is sufficient to prevent the age-related neurodegenerative phenotype of complex ganglioside-deficient mice. J Neurosci (2014) 0.82
Detection and prevalence of alpha-latrotoxin-like effects of serum from patients with Guillain-Barré syndrome. Muscle Nerve (2002) 0.81
Motor nerve terminal destruction and regeneration following anti-ganglioside antibody and complement-mediated injury: an in and ex vivo imaging study in the mouse. Exp Neurol (2011) 0.80
Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barré syndrome. Org Biomol Chem (2004) 0.79
Induction of human IgM and IgG anti-GM1 antibodies in transgenic mice in response to lipopolysaccharides from Campylobacter jejuni. J Neuroimmunol (2004) 0.78
Total ganglioside ablation at mouse motor nerve terminals alters neurotransmitter release level. Synapse (2010) 0.78
Glycosphingolipid depletion in PC12 cells using iminosugars protects neuronal membranes from anti-ganglioside antibody mediated injury. J Neuroimmunol (2008) 0.78
Ganglioside GM1 binding toxins and human neuropathy-associated IgM antibodies differentially promote neuritogenesis in a PC12 assay. Neurosci Res (2003) 0.78
Neurofascin antibodies in inflammatory neuropathy: how many needles make a haystack? Neurology (2012) 0.78
Autoantibodies in immune-mediated neuropathies. Curr Opin Neurol (2012) 0.77
Sulfatide binding properties of murine and human antiganglioside antibodies. Glycobiology (2007) 0.77
In vitro analysis of glial cell function in ganglioside-deficient mice. J Neurosci Res (2009) 0.77
Concanavalin A inhibits pathophysiological effects of anti-ganglioside GQ1b antibodies at the mouse neuromuscular synapse. Muscle Nerve (2005) 0.76
Peripheral neuropathies: Establishing common clinical research standards for CIDP. Nat Rev Neurol (2011) 0.76
The effects of age and ganglioside composition on the rate of motor nerve terminal regeneration following antibody-mediated injury in mice. Synapse (2013) 0.75
Sugar refining reveals a further specificity for autoantibodies in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry (2010) 0.75
A hazardous vapour trail from abattoir to neuropathy clinic. Lancet Neurol (2009) 0.75
Peripheral neuropathies: Biomarkers for axonal damage in immune-mediated neuropathy. Nat Rev Neurol (2009) 0.75